Wednesday, 28 August 2019

U.S. judge rules for Sanofi in Amgen patent fight

A U.S. judge on Wendesday largely set aside a jury verdict that Amgen Inc patents on its cholesterol drug Repatha were valid, handing a victory to Regeneron Pharmaceuticals Inc and Sanofi SA.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)